跳至主要内容
临床试验/ACTRN12612000082808
ACTRN12612000082808尚未招募未知

The Effect of Whole-Body Vibration Treatment on Bone Metabolism in Prostate Cancer Survivors who are undergoing Androgen Suppression Therapy

Edith Cowan University0 个研究点目标入组 50 人开始时间: 2012年1月17日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Male

入选标准

  • Undergoing androgen suppression therapy for prostate cancer
  • and are within one year of initiation of treatment.
  • Willing to continue taking any bone altering medications or supplements they were previously taking for the duration of the study, including calcium and vitamin D.
  • Able to stand unassisted for sustained periods of time (i.e. 20 minutes)

排除标准

  • Currently taking bisphosphonate medication;
  • Cognitive impairment;
  • Contraindications to vibration platform training (including pacemaker and fracture within the past six months);
  • Diagnosis of bone metastasis;
  • Diagnosis of diseases other than osteoporosis affecting bone

研究者

相似试验